Q2 2024 Earnings August 8, 2024 Forward-looking statements and non-GAAP financial measures This presentation contains certain forward-looking statements, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "anticipate," "believe," "could," "estimate," "e ...

Investor Presentation August 8, 2024 Disclaimers This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts, and further include, without limitation, statements reflecting the current views of TaskUs, Inc. ("TaskUs" or the "Company") with respect to, among other things, our operations, our financial performance, our industry, the impact of the current macro ...

Q2 2024 Earnings Call 2:00 pm PST August 8, 2024 Disclaimer This presentation and the accompanying oral presentation have been prepared by Amplitude, Inc. (the "Company"). Certain statements in this presentation and the accompanying oral commentary are forward-looking statements. These statements relate to the Company's financial outlook for the third quarter of 2024 and full year 2024, the expected performance of the Company's products, the Company's expected quarterly and long-term growth, investments, an ...

Universal Electronics Inc. Q2 2024 Results as of June 30, 2024 reported on August 8, 2024 SAFE HARBOR STATEMENT This presentation contains "forward-looking statements" within the meaning of federal securities laws, including net sales, profit margin and earnings trends, estimates and assumptions; our expectations about new product introductions; and similar statements concerning anticipated future events and expectations that are not historical facts. We caution you that these statements are not guarantees ...

| --- | --- | --- | --- | --- | |------------------|-------|-------------------|-------|-------| | | | | | | | | | Mattie | | | | | | Podder since 2010 | | | | | | | | | | | | | | | | Insulet | | | | | | Corporation | | | | | | Q2'24 Earnings | | | | | | August 8, 2024 | | | | | This presentation contains forward-looking statements regarding, among other things, future operating and financial performance, product success and efficacy, the outcome of studies and trials and the approval of products by regulat ...

veritone Investor Presentation August 2024 H U M A N H U M A A A N H U M H U M H U M a N Copyright @ 2024 Veritone, Inc. All rights reserved. Trademarks are the property of their respective owners. Forward-Looking Statements & Disclaimers This presentation of Veritone, Inc. (the "Company") contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. Without limiting the generality of the foregoing, words such ...

| --- | --- | |--------------------------------|-------| | | | | | | | | | | Earnings Presentation Q2 2024 | | | August 8, 2024 | | Safe Harbor This presentation contains forward-looking statements that involve substantial risks and uncertainties. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "anticipate," "could," "intend," "target," "estimate," "believe," "predict," "potential" or "continue" or the negative terms or other similar exp ...

| --- | --- | --- | |---------------------------------|-------|----------------------| | | | | | | | | | | | | | August 8, 2024 Q2 2024 Results | | | | | | We engineer enzymes | Forward Looking Statements 1 These slides contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial or operational performance and involve known and unknown risks, uncertainties and other factors that could cause our actual results or levels of activity, ...

Q2'24 Earnings Report ✈Collegium. PHARMACEUTICAL August 8, 2024 | Nasdaq: COLL Forward-Looking Statements 2 This presentation contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. We may, in some cases, use terms such as "predicts," "forecasts," "believes," "potential," "proposed," "continue," "estimates," "anticipates," "expects," "plans," "intends," "may," "could," "might," "should" or other words that convey uncertainty of future events or outcome ...

| --- | --- | --- | --- | --- | --- | |-----------------------------------------|---------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | EARNINGS CONFERENCE CALL August 8, 2024 | SECOND QUARTER 2024 | | | | | | DUSHYANT SHARMA President & CEO | SANJAY KALRA CFO | | | | | EARNINGS REPORT DISCLAIMER This presentation and the accompanying webcast contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All such statements, other ...